TITLE:
Evaluation in Diagnosis and Management of Diabetic Neuropathy
AUTHORS:
Wendy Waldman Zadeh, Pichit Thanupakorn
KEYWORDS:
Diabetic Neuropathy, Glycemic Control, Glycation End Products, Neuropathy Pain Medications, Preventive Medicine, Socioeconomic Status
JOURNAL NAME:
Journal of Diabetes Mellitus,
Vol.11 No.5,
November
18,
2021
ABSTRACT: The 100-year anniversary of insulin is explored by focusing on diabetic neuropathy. Neuropathy is so common to diabetes, it is well described even in the earliest accounts of diabetes. This article reviews the most common neuropathy syndromes, and the consensus of effective treatment for neuropathic pain. Pharmacological advances in neuropathy are still largely focused on pain control, not neuropathy intervention. The article reviews the established and lesser tested therapies used for pain control. It also reviews the pathophysiology of the disease state, including the many factors and steps that culminate to produce neuropathy and its different iterations. In the future, new ways to treat diabetic neuropathy may be geared toward treating specific pathophysiological step-points on the way to nerve damage. In the future, prevention and a deeper look at the impact of socioeconomic status as a predictor of diabetes will hopefully encompass a bigger part of pre-diabetic care.